(Q41183357)

27 September 2017

title

Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment (English)

1 reference

head and neck squamous cell carcinoma

27 September 2017

main subject

1 reference

10

Jean-Michel Prades

1 reference

27 September 2017

Coralie Moncharmont

1

1 reference

27 September 2017

Alexis Vallard

2

1 reference

27 September 2017

Sylvie Mengue Ndong

3

1 reference

27 September 2017

Jean-Baptiste Guy

4

1 reference

27 September 2017

Claire Saget

5

1 reference

27 September 2017

Benoîte Méry

6

1 reference

27 September 2017

Julien Langrand-Escure

7

1 reference

27 September 2017

Guy de Laroche

8

1 reference

27 September 2017

Dominique Goyet

9

1 reference

27 September 2017

Pierre Fournel

11

1 reference

27 September 2017

Nicolas Magné

12

1 reference

27 September 2017

language of work or name

English

0 references

publication date

27 October 2015

1 reference

27 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oto-Laryngologica

1 reference

27 September 2017

volume

136

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

181-188

1 reference

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

[Hypopharynx and larynx cancers: propositions for the selection and the delineation of peritumoral microscopic disease volumes (lymph nodes excluded)].

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00016489.2015.1101783

10.3109/00016489.2015.1101783

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference